P4-112: Sensitive task measure of memory function on the story recall test in patients with mild cognitive impairment and mild Alzheimer's disease

2015 ◽  
Vol 11 (7S_Part_17) ◽  
pp. P819-P819
Author(s):  
Kyung Won Park ◽  
Hyuntae Park ◽  
Jong-Hwan Park ◽  
Sang Wuk Sohn
2011 ◽  
Vol 18 (2) ◽  
pp. 214-229 ◽  
Author(s):  
Min J. Baek ◽  
Hyun J. Kim ◽  
Hui J. Ryu ◽  
Seoung H. Lee ◽  
Seol H. Han ◽  
...  

2012 ◽  
Vol 31 (1) ◽  
pp. 101-111 ◽  
Author(s):  
Yanyong Liu ◽  
Haji Akber Aisa ◽  
Chao Ji ◽  
Nan Yang ◽  
Haibo Zhu ◽  
...  

Aging-associated cognitive impairment is an important health care issue since individuals with mild cognitive impairment are more likely to develop Alzheimer’s disease. In the present study, the protective effect of Gossypium herbaceam extracts (GHE) on learning and memory impairment associated with aging were examined in vivo using Morris water maze and step through task. Furthermore, the antioxidant activity and neuroprotective effect of GHE was investigated with methods of histochemistry and biochemistry. These data showed that oral administration with GHE at the doses of 35, 70, and 140 mg/kg exerted an improved effect on the learning and memory impairment in aged rats. Subsequently, GHE afforded a beneficial action on eradication of free radicals without influence on the activity of glutathione peroxidase and superoxide dismutase. GHE treatment enhanced the expression levels of nerve growth factor. Meanwhile, proliferation of neural progenitor cells was elevated in hippocampus after treatment with GHE. Taken together, neurogenic niche improvement could be involved in the mechanism underlying neuroprotection of GHE against aging-associated cognitive impairment. These findings suggested that GHE might be a potential agent as cognitive-enhancing drugs that delay or halt mild cognitive impairment progression to Alzheimer’s disease or treatment of aging-associated cognitive impairment.


2009 ◽  
Vol 15 (2) ◽  
pp. 258-267 ◽  
Author(s):  
MEGAN G. SHEROD ◽  
H. RANDALL GRIFFITH ◽  
JACQUELYNN COPELAND ◽  
KATHERINE BELUE ◽  
SARA KRZYWANSKI ◽  
...  

AbstractFinancial capacity is a complex instrumental activity of daily living critical to independent functioning of older adults and sensitive to impairment in patients with amnestic mild cognitive impairment (MCI) and Alzheimer’s disease (AD). However, little is known about the neurocognitive basis of financial impairment in dementia. We developed cognitive models of financial capacity in cognitively healthy older adults (n = 85) and patients with MCI (n = 113) and mild AD (n = 43). All participants were administered the Financial Capacity Instrument (FCI) and a neuropsychological test battery. Univariate correlation and multiple regression procedures were used to develop cognitive models of overall FCI performance across groups. The control model (R2 = .38) comprised (in order of entry) written arithmetic skills, delayed story recall, and simple visuomotor sequencing. The MCI model (R2 = .69) comprised written arithmetic skills, visuomotor sequencing and set alternation, and race. The AD model (R2 = .65) comprised written arithmetic skills, simple visuomotor sequencing, and immediate story recall. Written arithmetic skills (WRAT-3 Arithmetic) was the primary predictor across models, accounting for 27% (control model), 46% (AD model), and 55% (MCI model) of variance. Executive function and verbal memory were secondary model predictors. The results offer insight into the cognitive basis of financial capacity across the dementia spectrum of cognitive aging, MCI, and AD. (JINS, 2009, 15, 258–267.)


2014 ◽  
Vol 14 (4) ◽  
pp. 758-762 ◽  
Author(s):  
Takanori Tanigawa ◽  
Hajime Takechi ◽  
Hidenori Arai ◽  
Minoru Yamada ◽  
Shu Nishiguchi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document